Combined use of prostaglandin compound and proton pump inhibitor for manufacture of a pharmaceutical composition for the treatment of gastrointestinal disorders and a pharmaceutical composition comprising them
摘要
<p>The present invention relates to combined use of (a) a specific prostaglandin (PG) compound and (b) a H<SUP>+</SUP>,K<SUP>+</SUP>-ATPase inhibitor for the treatment of gastrointestinal disorders.</p>
